FATE Annual Operating Expenses
$254.04 M
-$150.64 M-37.22%
31 December 2023
Summary:
As of January 23, 2025, FATE annual total operating expenses is $254.04 million, with the most recent change of -$150.64 million (-37.22%) on December 31, 2023. During the last 3 years, it has risen by +$94.53 million (+59.26%). FATE annual operating expenses is now -37.22% below its all-time high of $404.69 million, reached on December 31, 2022.FATE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FATE Quarterly Operating Expenses
$55.45 M
+$3.60 M+6.93%
30 September 2024
Summary:
As of January 23, 2025, FATE quarterly total operating expenses is $55.45 million, with the most recent change of +$3.60 million (+6.93%) on September 30, 2024. Over the past year, it has increased by +$2.23 million (+4.19%). FATE quarterly operating expenses is now -49.02% below its all-time high of $108.78 million, reached on December 31, 2022.FATE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FATE Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.2% | +4.2% |
| 3 y3 years | +59.3% | -36.7% |
| 5 y5 years | +253.7% | +49.8% |
FATE Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.2% | at low | -49.0% | +11.5% |
| 5 y | 5-year | -37.2% | +128.0% | -49.0% | +73.9% |
| alltime | all time | -37.2% | +1656.5% | -49.0% | +1348.6% |
Fate Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $55.45 M(+6.9%) |
| June 2024 | - | $51.85 M(-2.1%) |
| Mar 2024 | - | $52.99 M(+6.5%) |
| Dec 2023 | $254.04 M(-37.2%) | $49.75 M(-6.5%) |
| Sept 2023 | - | $53.22 M(-16.2%) |
| June 2023 | - | $63.50 M(-27.5%) |
| Mar 2023 | - | $87.57 M(-19.5%) |
| Dec 2022 | $404.69 M(+48.3%) | $108.78 M(+7.3%) |
| Sept 2022 | - | $101.37 M(-0.3%) |
| June 2022 | - | $101.66 M(+9.4%) |
| Mar 2022 | - | $92.88 M(+7.4%) |
| Dec 2021 | $272.84 M(+71.0%) | $86.45 M(+25.6%) |
| Sept 2021 | - | $68.85 M(+14.4%) |
| June 2021 | - | $60.19 M(+5.0%) |
| Mar 2021 | - | $57.35 M(+16.3%) |
| Dec 2020 | $159.52 M(+43.2%) | $49.30 M(+26.3%) |
| Sept 2020 | - | $39.05 M(+14.3%) |
| June 2020 | - | $34.17 M(-7.7%) |
| Mar 2020 | - | $37.01 M(+16.1%) |
| Dec 2019 | $111.41 M(+55.1%) | $31.88 M(+7.9%) |
| Sept 2019 | - | $29.55 M(+9.8%) |
| June 2019 | - | $26.90 M(+16.6%) |
| Mar 2019 | - | $23.08 M(+25.4%) |
| Dec 2018 | $71.83 M | $18.40 M(+3.9%) |
| Sept 2018 | - | $17.72 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $20.63 M(+36.8%) |
| Mar 2018 | - | $15.08 M(+13.6%) |
| Dec 2017 | $46.23 M(+27.1%) | $13.27 M(+16.8%) |
| Sept 2017 | - | $11.37 M(+7.3%) |
| June 2017 | - | $10.60 M(-3.7%) |
| Mar 2017 | - | $11.00 M(+26.7%) |
| Dec 2016 | $36.37 M(+20.4%) | $8.68 M(-7.8%) |
| Sept 2016 | - | $9.41 M(+4.3%) |
| June 2016 | - | $9.03 M(-2.2%) |
| Mar 2016 | - | $9.24 M(+15.6%) |
| Dec 2015 | $30.21 M(+21.3%) | $7.99 M(+8.6%) |
| Sept 2015 | - | $7.35 M(-2.6%) |
| June 2015 | - | $7.55 M(+3.0%) |
| Mar 2015 | - | $7.32 M(+23.2%) |
| Dec 2014 | $24.90 M(+33.6%) | $5.94 M(-0.7%) |
| Sept 2014 | - | $5.98 M(-0.9%) |
| June 2014 | - | $6.04 M(-12.9%) |
| Mar 2014 | - | $6.94 M(+41.5%) |
| Dec 2013 | $18.65 M(+14.9%) | $4.90 M(-8.5%) |
| Sept 2013 | - | $5.36 M(+17.5%) |
| June 2013 | - | $4.56 M(+19.1%) |
| Mar 2013 | - | $3.83 M(-18.3%) |
| Dec 2012 | $16.23 M(+12.2%) | $4.69 M(+12.2%) |
| Sept 2012 | - | $4.18 M |
| Dec 2011 | $14.46 M | - |
FAQ
- What is Fate Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Fate Therapeutics?
- What is Fate Therapeutics annual operating expenses year-on-year change?
- What is Fate Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Fate Therapeutics?
- What is Fate Therapeutics quarterly operating expenses year-on-year change?
What is Fate Therapeutics annual total operating expenses?
The current annual operating expenses of FATE is $254.04 M
What is the all time high annual operating expenses for Fate Therapeutics?
Fate Therapeutics all-time high annual total operating expenses is $404.69 M
What is Fate Therapeutics annual operating expenses year-on-year change?
Over the past year, FATE annual total operating expenses has changed by -$150.64 M (-37.22%)
What is Fate Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of FATE is $55.45 M
What is the all time high quarterly operating expenses for Fate Therapeutics?
Fate Therapeutics all-time high quarterly total operating expenses is $108.78 M
What is Fate Therapeutics quarterly operating expenses year-on-year change?
Over the past year, FATE quarterly total operating expenses has changed by +$2.23 M (+4.19%)